• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性嗜铬细胞瘤的迟发性恶性转移转化

Late Onset Malignant Metastatic Transformation of Benign Pheochromocytoma.

作者信息

Zafar Maha, Rajan Reshly M, Krishnakumar Manaswini, Reddy Aswanth

机构信息

Department of Internal Medicine, Mercy Hospital, Fort Smith, AR, United States.

Arkansas College of Osteopathic Medicine, AR, United States.

出版信息

J Community Hosp Intern Med Perspect. 2025 Jul 3;15(4):92-95. doi: 10.55729/2000-9666.1515. eCollection 2025.

DOI:10.55729/2000-9666.1515
PMID:40757220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12315872/
Abstract

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors arising from adrenal medulla and extra-adrenal paraganglia. Metastatic pheochromocytomas, pose diagnostic and therapeutic challenges due to their atypical presentations and potential for malignant transformation years after primary tumor resection. We report a case of 61-year-old woman who presented with intermittent cough, shortness of breath, and elevated blood pressure 6 years after resection of primary adrenal pheochromocytoma. Imaging revealed bilateral pulmonary nodules, a retroperitoneal mass, and L4 vertebral involvement, raising suspicion for metastatic pheochromocytoma. Elevated serum meta-nephrines and normetanephrines, alongside tissue biopsy and MIBG imaging, confirmed diagnosis. Germline genetic testing did not reveal any pathogenic mutations. The patient underwent CT-guided cryoablation for retroperitoneal lymph nodes and scheduled for radiofrequency ablation (RFA) of metastatic lesions. This case underscores evolving understanding of PPGLs, challenging "10 % rule" regarding metastasis and inheritance. While mutations in genes such as SDHB are associated with increased metastatic risk, sporadic cases like this highlight need for lifelong surveillance in all patients' post-resection of primary tumor. Ablative techniques, EBRT, and emerging systemic therapies are promising methods for managing metastatic disease. This case highlights importance of long-term follow-up and genetic testing in patients with PPGLs, even in absence of hereditary mutations, to detect and manage late-onset metastatic disease efficiently.

摘要

嗜铬细胞瘤和副神经节瘤(PPGLs)是起源于肾上腺髓质和肾上腺外副神经节的罕见神经内分泌肿瘤。转移性嗜铬细胞瘤因其非典型表现以及在原发性肿瘤切除数年之后发生恶性转化的可能性,给诊断和治疗带来了挑战。我们报告了一例61岁女性患者,她在原发性肾上腺嗜铬细胞瘤切除术后6年出现间歇性咳嗽、气短和血压升高。影像学检查发现双侧肺结节、腹膜后肿块以及L4椎体受累,这引发了对转移性嗜铬细胞瘤的怀疑。血清间甲肾上腺素和去甲间甲肾上腺素升高,同时结合组织活检和MIBG显像,确诊了该病。胚系基因检测未发现任何致病突变。该患者接受了CT引导下的腹膜后淋巴结冷冻消融术,并计划对转移性病灶进行射频消融(RFA)。该病例强调了对PPGLs不断演变的认识,对关于转移和遗传的“10%规则”提出了挑战。虽然SDHB等基因的突变与转移风险增加有关,但像这样的散发性病例凸显了对所有原发性肿瘤切除术后患者进行终身监测的必要性。消融技术、外照射放疗(EBRT)以及新兴的全身治疗方法是治疗转移性疾病的有前景的方法。该病例突出了对PPGLs患者进行长期随访和基因检测的重要性,即使没有遗传性突变,也能有效地检测和管理迟发性转移性疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/596c/12315872/aa33a47dd2b4/jchim-15-04-092f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/596c/12315872/645b2218e6ed/jchim-15-04-092f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/596c/12315872/aa33a47dd2b4/jchim-15-04-092f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/596c/12315872/645b2218e6ed/jchim-15-04-092f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/596c/12315872/aa33a47dd2b4/jchim-15-04-092f2.jpg

相似文献

1
Late Onset Malignant Metastatic Transformation of Benign Pheochromocytoma.良性嗜铬细胞瘤的迟发性恶性转移转化
J Community Hosp Intern Med Perspect. 2025 Jul 3;15(4):92-95. doi: 10.55729/2000-9666.1515. eCollection 2025.
2
Hereditary Paraganglioma-Pheochromocytoma Syndromes遗传性副神经节瘤-嗜铬细胞瘤综合征
3
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop.遗传性内分泌肿瘤:最新研究进展和研究机遇:转移性嗜铬细胞瘤和副神经节瘤: MEN2019 研讨会纪要。
Endocr Relat Cancer. 2020 Aug;27(8):T41-T52. doi: 10.1530/ERC-19-0435.
4
Evaluating the diagnostic accuracy of Tc-labeled somatostatin receptor imaging for suspected pheochromocytomas and paragangliomas.评估锝标记的生长抑素受体显像对疑似嗜铬细胞瘤和副神经节瘤的诊断准确性。
Sci Rep. 2025 Jul 28;15(1):27493. doi: 10.1038/s41598-025-12794-x.
5
Pheochromocytoma and Paraganglioma嗜铬细胞瘤和副神经节瘤
6
Multiple Endocrine Neoplasia Type 22型多发性内分泌腺瘤病
7
PEComa with metastatic pulmonary embolism upon presentation: A case report.初诊时伴转移性肺栓塞的PEComa:一例报告
Radiol Case Rep. 2025 Jun 24;20(9):4561-4566. doi: 10.1016/j.radcr.2025.06.009. eCollection 2025 Sep.
8
Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.射频消融治疗结直肠癌肝转移
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD006317. doi: 10.1002/14651858.CD006317.pub3.
9
Von Hippel-Lindau Syndrome冯·希佩尔-林道综合征
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Management of metastatic pheochromocytomas and paragangliomas: when and what.转移性嗜铬细胞瘤和副神经节瘤的治疗:何时及何种治疗。
Curr Probl Cancer. 2024 Aug;51:101116. doi: 10.1016/j.currproblcancer.2024.101116. Epub 2024 Jul 17.
2
Multi-disciplinary surgery for simultaneous resection of multiple tumors in a patient with newly diagnosed metastatic pheochromocytoma/paraganglioma.多学科手术用于同时切除新诊断的转移性嗜铬细胞瘤/副神经节瘤患者的多个肿瘤。
Cancer Pathog Ther. 2023 May 22;1(4):290-294. doi: 10.1016/j.cpt.2023.05.003. eCollection 2023 Oct.
3
Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.
处理嗜铬细胞瘤和副神经节瘤:当前诊断和治疗选择的综述。
Cancer Med. 2023 Jul;12(13):13942-13957. doi: 10.1002/cam4.6010. Epub 2023 May 5.
4
SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis.SDHB 免疫组化在嗜铬细胞瘤和副神经节瘤预后中的作用:回顾性和前瞻性分析。
Front Endocrinol (Lausanne). 2023 Mar 16;14:1121397. doi: 10.3389/fendo.2023.1121397. eCollection 2023.
5
Genetic bases of pheochromocytoma and paraganglioma.嗜铬细胞瘤和副神经节瘤的遗传学基础。
J Mol Endocrinol. 2023 Jan 24;70(3). doi: 10.1530/JME-22-0167. Print 2023 Apr 1.
6
Personalized Management of Pheochromocytoma and Paraganglioma.《嗜铬细胞瘤和副神经节瘤的个体化管理》
Endocr Rev. 2022 Mar 9;43(2):199-239. doi: 10.1210/endrev/bnab019.
7
Malignant pheochromocytoma: A diagnostic and therapeutic dilemma.恶性嗜铬细胞瘤:诊断与治疗的困境
Int J Surg Case Rep. 2021 Jun;83:106009. doi: 10.1016/j.ijscr.2021.106009. Epub 2021 May 24.
8
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.《嗜铬细胞瘤和副神经节瘤的诊断、遗传咨询和治疗的多学科实践指南》。
Clin Transl Oncol. 2021 Oct;23(10):1995-2019. doi: 10.1007/s12094-021-02622-9. Epub 2021 May 6.
9
Preoperative Management of Pheochromocytoma and Paraganglioma.《嗜铬细胞瘤和副神经节瘤的术前管理》。
Front Endocrinol (Lausanne). 2020 Sep 29;11:586795. doi: 10.3389/fendo.2020.586795. eCollection 2020.
10
177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma.177镥-奥曲肽治疗转移性/不可切除的嗜铬细胞瘤-副神经节瘤
Endocr Connect. 2020 Oct;9(9):864-873. doi: 10.1530/EC-20-0292.